Close
Nordic 9Nordic 9

Ferrosa Therapeutics (private company)

Switzerland
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechHealth servicesPharma
Business model:B2B

Ferrosa Therapeutics is a Swiss biotech startup building a first-in-class bispecific antibody program targeting Anemia of Inflammation — a major unmet need across chronic kidney disease, autoimmune disorders, and oncology.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.5M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Ferrosa Therapeutics

Name Criteria
Sweden Athera
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Ilya Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Abarceo Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pila Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Betagenon
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Kintsugi Therapeutics
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Vaxxel
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top